The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

Migraine patients often suffer a long time before docs zero in on the best dosage for drugs designed to prevent thei ...

The prevalence of post-COVID-19 condition (PCC) was 8.4 percent among U.S. adults in 2023, according to a research l ...

Buprenorphine dispensing increased among adolescents and decreased among young adults between 2020 and 2023, accordi ...

Gestational hypertension, preeclampsia, and eclampsia are associated with an increased risk for neurological outcome ...

For patients hospitalized for COVID-19, administration of therapeutic-dose versus prophylactic-dose anticoagulation ...

For adults with migraine, atogepant 60 mg once daily was superior to placebo for efficacy and functional measures of ...

COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disabilit ...

Multimorbidity is strongly associated with accelerated kidney function decline in older age, according to a study pu ...

THURSDAY, Dec. 26, 2024 (HealthDay News) -- A brief outpatient rehabilitation program with a cognitive and behavioral ...

The U.S. Food and Drug Administration (FDA) has escalated the recall of certain eggs sold at Costco to its highest C ...

Dosing yourself with your favorite morning brew, whether it’s coffee or tea, may help protect you from certain types of ...